Purpose Patients with atrial fibrillation are at increased risk for stroke and thus require
anticoagulant prophylaxis with vitamin K antagonists. However, many such patients fail to …

Objective We assessed the influence of age on warfarin dose, percentage time in target
range (PTTR), and risk of major hemorrhage. Design Warfarin users recruited into a large …

Evaluation of Time in Therapeutic Range (TTR) in Patients with Non-Valvular Atrial Fibrillation
Receiving Treatment with Warfarin in Tehran, Iran: A Cross-Sectional Study - PMC Back to Top …

This systematic review aims to provide an update on pharmacology, efficacy and safety of
the newer oral direct thrombin and factor Xa inhibitors, which have emerged for the first time …

Objective We evaluated whether percent time in target range (PTTR), risk of over-
anticoagulation [international normalized ratio (INR)> 4], and risk of hemorrhage differ by …

A cross-sectional study was conducted to predict time in therapeutic range (TTR) using
clinical history, examination, and socioeconomic data. Study included warfarin-receiving …

BACKGROUND: Warfarin is a common treatment option to manage patients with
nonvalvular atrial fibrillation (NVAF) in clinical practice. Understanding current pharmacist …

Background The quality of antithrombotic therapy for patients with nonvalvular atrial
fibrillation during routine medical care is often suboptimal. Evidence linking stroke and …

Results For all patients, the INR values were higher in the CP (2.47 vs 2.60, p< 0.001), and
the NIM percentage was higher (19.2% vs 71.5%, p< 0.001) in the CP. The number of INR …

Background Vitamin K antagonists, despite their tight therapeutic spectrum and the fear of
bleeding complications, were long the most important drugs used in anticoagulant therapy …